Applied Therapeutics Stock Performance
| APLT Stock | USD 10.21 0.62 6.47% |
Applied Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Applied Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Applied Therapeutics is expected to be smaller as well. Use Applied Therapeutics semi variance, and the relationship between the treynor ratio and daily balance of power , to analyze future returns on Applied Therapeutics.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Applied Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Applied Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (7.54) | Five Day Return 0.96 | Year To Date Return 159.34 | Ten Year Return 0.43 | All Time Return 0.43 |
1 | Applied Therapeutics Shares Gap Up to 4.65 | 09/18/2024 |
2 | APLT Stock Soars 69 percent on Positive Update on Galactosemia Drug NDA | 09/19/2024 |
3 | All You Need to Know About Applied Therapeutics Rating Upgrade to Buy | 09/23/2024 |
4 | Is Applied Therapeutics Stock Outpacing Its Medical Peers This Year | 09/24/2024 |
5 | Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference | 09/30/2024 |
6 | Applied Therapeutics Trading Down 2.2 percent Heres What Happened | 10/16/2024 |
7 | Applied Therapeutics Upgraded to Buy Heres What You Should Know | 10/29/2024 |
8 | Morgan Stanleys Strategic Acquisition of Applied Therapeutics Inc Shares | 11/07/2024 |
9 | Disposition of 12375 shares by Marcus Joel S of Applied Therapeutics at 1.05 subject to Rule 16b-3 | 11/08/2024 |
10 | Perceptive Advisors LLC Expands Stake in Applied Therapeutics Inc | 11/15/2024 |
| Begin Period Cash Flow | 16.7 M |
Applied |
Applied Therapeutics Relative Risk vs. Return Landscape
If you would invest 608.00 in Applied Therapeutics on August 29, 2024 and sell it today you would earn a total of 413.00 from holding Applied Therapeutics or generate 67.93% return on investment over 90 days. Applied Therapeutics is currently generating 1.1319% in daily expected returns and assumes 9.3186% risk (volatility on return distribution) over the 90 days horizon. In different words, 82% of stocks are less volatile than Applied, and 78% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Applied Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Applied Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Applied Therapeutics, and traders can use it to determine the average amount a Applied Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1215
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | APLT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.32 actual daily | 82 82% of assets are less volatile |
Expected Return
| 1.13 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Applied Therapeutics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Applied Therapeutics by adding it to a well-diversified portfolio.
Applied Therapeutics Fundamentals Growth
Applied Stock prices reflect investors' perceptions of the future prospects and financial health of Applied Therapeutics, and Applied Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Applied Stock performance.
| Return On Equity | -4.73 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (243.80) % | ||||
| Current Valuation | 1.09 B | ||||
| Shares Outstanding | 116.36 M | ||||
| Price To Earning | (7.46) X | ||||
| Price To Book | 201.63 X | ||||
| Price To Sales | 54.68 X | ||||
| Revenue | 9.99 M | ||||
| EBITDA | (64.53 M) | ||||
| Net Income | (119.76 M) | ||||
| Cash And Equivalents | 67.72 M | ||||
| Cash Per Share | 1.41 X | ||||
| Total Debt | 777 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 1.49 X | ||||
| Book Value Per Share | 0.05 X | ||||
| Cash Flow From Operations | (55.17 M) | ||||
| Earnings Per Share | (1.42) X | ||||
| Market Capitalization | 1.19 B | ||||
| Total Asset | 54.83 M | ||||
| Retained Earnings | (468.59 M) | ||||
| Working Capital | (16.8 M) | ||||
| Current Asset | 37.74 M | ||||
| Current Liabilities | 11.19 M | ||||
About Applied Therapeutics Performance
Assessing Applied Therapeutics' fundamental ratios provides investors with valuable insights into Applied Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Applied Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (204.85) | (215.09) | |
| Return On Tangible Assets | (2.18) | (2.29) | |
| Return On Capital Employed | 3.95 | 4.14 | |
| Return On Assets | (2.18) | (2.29) | |
| Return On Equity | 6.98 | 7.33 |
Things to note about Applied Therapeutics performance evaluation
Checking the ongoing alerts about Applied Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Applied Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Applied Therapeutics is way too risky over 90 days horizon | |
| Applied Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 9.99 M. Net Loss for the year was (119.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Applied Therapeutics currently holds about 67.72 M in cash with (55.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.41. | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Perceptive Advisors LLC Expands Stake in Applied Therapeutics Inc |
- Analyzing Applied Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Applied Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Applied Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Applied Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Applied Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Applied Therapeutics' stock. These opinions can provide insight into Applied Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.